CN104274582B - 一种用于护肝的药物组合物及其制备方法 - Google Patents
一种用于护肝的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN104274582B CN104274582B CN201410541622.5A CN201410541622A CN104274582B CN 104274582 B CN104274582 B CN 104274582B CN 201410541622 A CN201410541622 A CN 201410541622A CN 104274582 B CN104274582 B CN 104274582B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- liver
- effective ingredient
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 239000010231 banlangen Substances 0.000 claims abstract description 11
- 210000002826 placenta Anatomy 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 7
- 239000002671 adjuvant Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims description 6
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 2
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 241000700721 Hepatitis B virus Species 0.000 abstract description 3
- 108090000340 Transaminases Proteins 0.000 abstract description 3
- 102000003929 Transaminases Human genes 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000002672 hepatitis B Diseases 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 4
- 231100000753 hepatic injury Toxicity 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 206010019847 hepatosplenomegaly Diseases 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 201000001862 viral hepatitis Diseases 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000709715 Hepatovirus Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
- 229960001627 lamivudine Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种用于护肝的药物组合物,该药物组合物由有效成分和药学上可接受的辅料组成,其特征在于,所述的有效成分由以下重量份的原料药制成:女贞子1.5~2.5份,五味子0.5~1.5份,淫羊藿1~1.5份,虎杖2~3份,紫河车1~1.5份,刺五加1~2份,黄芪1~1.5份,丹皮1~2份,板蓝根1~2份,黄芩0.5~1.5份,桑寄生0.5~1.5份,柴胡0.5~1.5份。本发明所述药物组合物的功能在于滋养肝肾,清热解毒,调和气血,同时药物对乙肝病毒有抑制作用,降低转氨酶,增强机体免疫功能,该处方毒副作用极小,治疗作用明显,为肝损伤患者提供了一种理想的药物。
Description
技术领域
本发明涉及一种医用配制品,具体涉及以中药为原料制备的中成药。
背景技术
慢性乙型肝炎是我国常见病、多发病,危害各年龄层人群的健康,肝病时肝功能有不同程度的损害,肝脏解毒、排泄功能及贮备和再生能力降低,肝血流量减少,各种进入肝脏的药物使代谢负荷加重,从而发生内环境紊乱,进而造成肝损伤,长期的肝损伤可以导致肝硬化甚至肝癌。
目前,临床上普遍采用干扰素治疗慢性乙肝,虽然使用范围广,但疗效却越来越令人失望,同时干扰素治疗乙肝有适应症,有明显不良反应,与我国的肝病特点不符;另外一个常用药拉米夫定在其应用初期,以抑制病毒迅速,乙肝病毒DNA转阴率高,不良反应较轻、较少,价格相对低廉等优点,得到医生和患者的青睐,随着治疗时间的延长,问题慢慢浮现出来;如诱导乙肝病毒的变异,先喜后忧的现实,较窄的适应证,有限的治疗效果,遥遥无期的疗程,停药后的“反弹”,并且可能使病情明显加重,甚至恶化。
我国是肝炎高发大国,现有各类型肝病患者已超过2亿,大多需要具有肝脏保护作用的药物,代医学对肝损伤的研究比较深入,已从多方面探讨了肝损伤的发生机制,并研制开发出多种保肝药物,但疗效尚难尽人意;中药有着多靶点、多环节综合作用的特点,在治疗肝损伤方面有独特的优势。
发明内容
本发明目的就是按照中医药理论科学组方,采用现代提取、制剂工艺研制出一种具有改善肝功能、降低转氨酶的药物。
本发明实现上述目的的技术方案为:
一种用于护肝的药物组合物,该药物组合物由有效成分和药学上可接受的辅料组成,其特征在于,所述的有效成分由以下重量份的原料药制成:女贞子1.5~2.5份,五味子0.5~1.5份,淫羊藿1~1.5份,虎杖2~3份,紫河车1~1.5份,刺五加1~2份,黄芪1~1.5份,丹皮1~2份,板蓝根1~2份,黄芩0.5~1.5份,桑寄生0.5~1.5份,柴胡0.5~1.5份。
上述药物组合物中有效成分由以下重量份的原料药制成:女贞子2份、五味子1份、淫羊藿1.3份、虎杖2.5份、紫河车1.3份、刺五加1.5份、黄芪1.3份、丹皮1.5份、板蓝根1.5份、黄芩1.1份、桑寄生1.1份、柴胡1份。
上述药物组合物由以下方法制成:取女贞子、五味子、虎杖和黄芩采用乙醇提取,回收乙醇后得浸膏A;取淫羊藿、刺五加、黄芪、板蓝根、桑寄生、柴胡、紫河车采用水煎煮提取,提取液浓缩成浸膏后,加入乙醇至醇浓度大于50%,滤除沉淀,上清液浓缩得浸膏B;丹皮采用水蒸汽蒸馏提取得到丹皮酚;将浸膏A和B混匀,加入药用淀粉和/或糊精干燥后与丹皮酚混匀粉碎,再采用常规工艺制成片剂或胶囊剂。
本发明所述的药物组合物,方中以桑寄生、淫羊藿为君,滋肾养肝;再以黄芪益气固本,女贞子、紫河车滋阴养血,五味子、刺五加养肝降酶,共为臣药;佐以虎杖、板蓝根、丹皮清热凉血解毒;醋柴胡疏肝解郁、引药入肝为使药。现代药理研究表明:板蓝根、虎杖、黄芩、柴胡对乙肝病毒有抑制作用;五味子、刺五加具有降低转氨酶作用;黄芪、女贞子、淫羊藿可以增强机体免疫功能。因此,不但中医传统理论与临床实践,抑或现代药理研究均表明本处方组方法度严谨,依据充分。
具体实施方式
药物制剂的制备:取女贞子20千克、五味子10千克、淫羊藿13千克、虎杖25千克、紫河车13千克、刺五加15千克、黄芪13千克、丹皮15千克、板蓝根15千克、黄芩11千克、桑寄生11千克、柴胡10千克。按照如下工艺,女贞子、五味子、虎杖、黄芩四味中药混合后采用乙醇提取两次,每次加70%乙醇6倍量回流提取1小时,回收乙醇后得浸膏A;淫羊藿、刺五加、黄芪、板蓝根、桑寄生、柴胡、紫河车7味中药,采用水煎煮提取两次,每次加水10倍量提取两次,提取液浓缩成相对密度约在1.20的浸膏后,加入乙醇至醇浓度为60%,滤除沉淀,上清液浓缩得浸膏B;丹皮采用水蒸汽蒸馏的方法提取得到丹皮酚;将浸膏A和B混匀,加入药用淀粉和/或糊精干燥后与丹皮酚混匀粉碎,装入胶囊,即得。
临床应用研究:慢性乙型肝炎诊断按1990年第6次全国肝病会议制定的慢性乙型肝炎诊断标准。120例分为治疗组80例,对照组40例。治疗组80例中男52例,女28例;年龄最小18岁,最大62岁,平均31.71±8.12岁;病程1-8年,平均3.31±2.53年。对照组40例中男25例,女15例;年龄最小19岁,最大63岁,平均3.25±7.93岁。病程1-9年,平均3.35±2.71年。根据卫生部1993年10月制定的《中药新药治疗病毒性肝炎的临床研究指导原则》作辨证分型。湿热薰蒸证:治疗组19例,对照组9例;瘀毒内结证:治疗组25例,对照组13例;气滞血瘀证:治疗组36例,对照组18例。以上两组资料经统计学处理无显著性差异(P>0.05)。
治疗方法治疗组用该方制剂口服,每次3粒,1日3次。对照组采用联苯双酯滴丸15mg,维生素C200mg,肝泰乐0.2g,每日3次口服。4周为一个疗程,可连续治疗2-3个疗程,治疗结束后作疗效评定。
疗效标准根据卫生部1993年10月制定《中药新药治疗病毒性肝炎(慢性肝炎)的临床研究指导原则》中的标准作疗效评定。
基本治愈:自觉症状消失;肝脾肿大稳定不变或缩小,无压痛及叩痛;肝功能检查正常;以上各项指标稳定1年以上者。
有效:主要症状消失,或基本消失;肝脾肿大稳定不变,且无明显压痛及叩痛;肝功能检查正常或原值下降50%以上,并持续3个月者。
无效:疗程结束后,SGPT不下降者。
治疗结果治疗组80例,基本治愈26例,显效28例,有效20例,无效6例,总有效率为92.5%。对照组40例,其中治愈7例,显效9例,有效9例,无效15例,总有效率为62.5%,两组临床疗效比较,有显著性意义(卡方检验P<0.01)。
不良反应:治疗前后对血常规、肝、肾功能检测未发现损害现象。
Claims (3)
1.一种用于护肝的药物组合物,该药物组合物由有效成分和药学上可接受的辅料组成,其特征在于,所述的有效成分由以下重量份的原料药制成:女贞子1.5~2.5份,五味子0.5~1.5份,淫羊藿1~1.5份,虎杖2~3份,紫河车1~1.5份,刺五加1~2份,黄芪1~1.5份,丹皮1~2份,板蓝根1~2份,黄芩0.5~1.5份,桑寄生0.5~1.5份,柴胡0.5~1.5份。
2.根据权利要求1所述的一种用于护肝的药物组合物,其特征在于,所述的有效成分由以下重量份的原料药制成:由女贞子2份,五味子1份,淫羊藿1.3份,虎杖2.5份,紫河车1.3份,刺五加1.5份,黄芪1.3份,丹皮1.5份,板蓝根1.5份,黄芩1.1份,桑寄生1.1份,柴胡1份。
3.一种制备权利要求1或2所述的用于护肝的药物组合物的方法,该方法由以下步骤组成:取女贞子、五味子、虎杖和黄芩采用乙醇提取,回收乙醇后得浸膏A;取淫羊藿、刺五加、黄芪、板蓝根、桑寄生、柴胡、紫河车采用水煎煮提取,提取液浓缩成浸膏后,加入乙醇至醇浓度大于50%,滤除沉淀,上清液浓缩得浸膏B;丹皮采用水蒸气蒸馏提取得到丹皮酚;将浸膏A和B混匀,加入药用淀粉和/或糊精干燥后与丹皮酚混匀粉碎,再采用常规工艺制成片剂或胶囊剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410541622.5A CN104274582B (zh) | 2014-10-14 | 2014-10-14 | 一种用于护肝的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410541622.5A CN104274582B (zh) | 2014-10-14 | 2014-10-14 | 一种用于护肝的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104274582A CN104274582A (zh) | 2015-01-14 |
CN104274582B true CN104274582B (zh) | 2016-08-17 |
Family
ID=52250243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410541622.5A Active CN104274582B (zh) | 2014-10-14 | 2014-10-14 | 一种用于护肝的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104274582B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1044974C (zh) * | 1994-06-17 | 1999-09-08 | 殷广全 | 抗乙肝药物 |
-
2014
- 2014-10-14 CN CN201410541622.5A patent/CN104274582B/zh active Active
Non-Patent Citations (2)
Title |
---|
慢性乙型肝炎患者中医证型特点及分布规律的初探;凌琪华等;《中医杂志》;20110630;第52卷;第82-83页 * |
疏肝化瘀解毒方治疗慢性乙型肝炎180例观察;李忠诚等;《现代中医药》;20021231(第5期);第21-22页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104274582A (zh) | 2015-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021179505A1 (zh) | 一种翘芪复方制剂及其制备方法和用途 | |
CN103751497A (zh) | 一种治疗乳腺炎的药物及其制备方法 | |
CN103432545B (zh) | 一种用于小儿退烧的药物及其制备方法 | |
AU2024205781A1 (en) | Combined plant compounds for use in the treatment of viral infections including covid-19 | |
CN104689173B (zh) | 一种治疗痛风的中药复方制剂 | |
CN116139237B (zh) | 一种防治新型冠状病毒等所致呼吸道感染的中药组合物及其应用 | |
CN111714553A (zh) | 一种用于新冠肺炎和/或流行性感冒的中药组合物及其制备方法 | |
CN103356932B (zh) | 一种治疗外阴鳞状上皮细胞增生的药物组合物 | |
CN104337989A (zh) | 一种含鹅不食草和乳香的治疗痛风的中药组合物 | |
CN104274582B (zh) | 一种用于护肝的药物组合物及其制备方法 | |
CN104435567A (zh) | 一种含绞股蓝的治疗痛风的中药组合物 | |
CN104095940B (zh) | 一种治疗痛风的中药组合物 | |
CN105012612A (zh) | 一种治疗骨质增生的中药组合物 | |
CN105194207A (zh) | 一种中药组合物及其用途 | |
CN104740579B (zh) | 经前安片及其制备工艺 | |
CN103585517A (zh) | 一种治疗肝炎、胆囊炎的药物组合物及其制备方法 | |
CN112755137B (zh) | 一种治疗轻中度膝骨关节炎的中药组合物及其应用 | |
CN1190215C (zh) | 治疗风湿类疾病的中草药剂 | |
CN116270922B (zh) | 化浊散结除痹方及其应用 | |
CN103341094B (zh) | 一种治疗外阴鳞状上皮细胞增生的散剂制备方法 | |
CN103316270B (zh) | 一种治疗产后会阴粘膜病变药物的散剂制备方法 | |
CN1994415B (zh) | 一种治疗痛经的内服中药 | |
CN105663612A (zh) | 一种治疗强直性脊柱炎的中药组合物 | |
CN104740578B (zh) | 经前安片制备工艺及其检测方法 | |
CN103316258B (zh) | 一种治疗婴幼儿阴道炎的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170413 Address after: 510000 Guangdong, Baiyun District, Sha Tai Road South, the third floor of science and technology building, No. 1023 Patentee after: Guangdong Nanfang Medical Technology Development Co Ltd Address before: 510515 Baiyun District, Guangdong, Guangzhou, Sha Tai Road, No. 1023 Patentee before: Southern Medical University |
|
TR01 | Transfer of patent right |